Journal for ImmunoTherapy of Cancer,
Journal Year:
2024,
Volume and Issue:
12(8), P. e009728 - e009728
Published: Aug. 1, 2024
Background
Immune
checkpoint
inhibitors
(ICIs)
have
been
a
major
advance
in
cancer
management.
However,
we
still
lack
prospective
real-world
data
regarding
their
usage
people
with
HIV
infection
(PWH).
Methods
The
ANRS
CO24
OncoVIHAC
study
(
NCT03354936
)
is
an
ongoing
observational
cohort
France
of
PWH
treated
ICI.
We
assessed
the
incidence
grade
≥3
immune-related
adverse
events
(irAEs).
All
irAEs
were
reviewed
by
event
review.
Results
Between
January
17,
2018,
and
December
05,
2023,
150
participants
recruited
from
33
sites
140
included
this
analysis.
At
cut-off
date
median
follow-up
was
9.2
months
(IQR:
3.9–18.3),
total
126.2
person-years.
Median
age
59
years
54–64)
111
(79.3%)
men.
time
since
diagnosis
25
(12–31),
duration
on
antiretroviral
(ARV)
19.5
(7.7–25.4),
CD4
nadir
117/µL
(51–240).
ICI
regimens
comprised
anti-programmed
cell
death
protein-1
(PD-1)
for
participants,
death-ligand
1
(17.9%),
combination
anti-PD-1
anti-cytotoxic
T-lymphocyte
associated
protein
4
3
(2.1%),
along
anti-vascular
endothelial
growth
factor
receptor
(0.7%).
most
frequent
cancers
lung
(n=65),
head/neck
(n=15),
melanoma
(n=12),
liver
(n=11)
Hodgkin’s
lymphoma
(n=9).
During
follow-up,
34
occurred
20
leading
to
rate
26.9
per
100
Kaplan-Meier
estimates
proportion
at
least
one
episode
13.8%
6
months,
15.0%
12
18.7%
18
months.
One
treatment-related
due
myocarditis
reported
Multivariable
analysis
cumulative
showed
that
>17
(incidence
ratio
(IRR)=4.66,
p=0.002),
CD4<200
cells/µL
(IRR=4.39,
p<0.0001),
positive
cytomegalovirus
(CMV)
serology
(IRR=2.76,
p=0.034),
history
surgery
(IRR=3.44,
p=0.001)
had
higher
risk
irAEs.
Conclusion
This
first
irAE
(95%
CI:
9.6%
22.9%)
year
all
severe
episodes
Low
count,
CMV
serology,
longer
occurrence
Medicine,
Journal Year:
2024,
Volume and Issue:
103(2), P. e36937 - e36937
Published: Jan. 12, 2024
This
review
delves
into
the
intricate
relationship
between
anemia,
iron
metabolism,
and
human
immunodeficiency
virus
(HIV),
aiming
to
unravel
interconnected
pathways
that
contribute
complex
interplay
these
3
entities.
A
systematic
exploration
of
relevant
literature
was
conducted,
encompassing
studies
examining
association
status,
HIV
infection.
Both
clinical
preclinical
investigations
were
analyzed
elucidate
underlying
mechanisms
linking
components.
Chronic
inflammation,
a
hallmark
infection,
disrupts
homeostasis,
impacting
erythropoiesis
contributing
anemia.
Direct
viral
effects
on
bone
marrow
function
further
compound
red
blood
cell
deficiencies.
Antiretroviral
therapy,
while
essential
for
managing
HIV,
introduces
potential
complications,
including
medication-induced
Dysregulation
levels
in
different
tissues
adds
complexity
network
interactions.
Effective
management
anemia
necessitates
multifaceted
approach.
Optimization
antiretroviral
treatment
opportunistic
infections,
targeted
nutritional
interventions,
supplementation,
are
integral
However,
challenges
persist
understanding
specific
molecular
governing
pathways.
Decoding
is
imperative
enhancing
holistic
care
individuals
with
HIV/AIDS.
nuanced
relationships
will
inform
development
more
precise
optimizing
this
population.
Future
research
endeavors
should
focus
elucidating
mechanisms,
paving
way
innovative
therapeutic
strategies
context
HIV-associated
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Jan. 7, 2025
Abstract
The
mucosal
immune
system,
as
the
most
extensive
peripheral
network,
serves
frontline
defense
against
a
myriad
of
microbial
and
dietary
antigens.
It
is
crucial
in
preventing
pathogen
invasion
establishing
tolerance.
A
comprehensive
understanding
immunity
essential
for
developing
treatments
that
can
effectively
target
diseases
at
their
entry
points,
thereby
minimizing
overall
impact
on
body.
Despite
its
importance,
our
knowledge
remains
incomplete,
necessitating
further
research.
outbreak
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
underscored
critical
role
disease
prevention
treatment.
This
systematic
review
focuses
dynamic
interactions
between
mucosa-associated
lymphoid
structures
related
diseases.
We
delve
into
basic
functions
these
tissues
during
processes
explore
intricate
regulatory
networks
mechanisms
involved.
Additionally,
we
summarize
novel
therapies
clinical
research
advances
immunity-related
also
addresses
challenges
vaccines,
which
aim
to
induce
specific
responses
while
maintaining
tolerance
non-pathogenic
microbes.
Innovative
therapies,
such
nanoparticle
vaccines
inhalable
antibodies,
show
promise
enhancing
offer
potential
improved
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 10, 2025
People
living
with
HIV
(PLWH)
have
an
increased
risk
for
developing
tuberculosis
after
M.
infection,
despite
anti-retroviral
therapy
(ART).
To
delineate
the
underlying
mechanisms,
we
conducted
single
cell
transcriptomics
on
bronchoalveolar
lavage
cells
from
PLWH
ART
and
uninfected
healthy
controls
infected
ex
vivo.
We
identify
M1-like
proinflammatory
alveolar
macrophage
subset
that
sequentially
acquires
TNF
signaling
capacity
in
but
not
PLWH.
Cell-cell
communication
analyses
reveal
interactions
between
macrophages
effector
memory
T
within
superfamily,
chemokine,
costimulatory
networks
airways
of
controls.
These
interaction
were
lacking
tuberculosis,
where
anti-inflammatory
M2-like
regulatory
dominated
along
dysregulated
signatures.
Our
data
support
a
model
which
impaired
TNF-TNFR
signaling,
aberrant
macrophage-T
crosstalk,
lead
to
ineffective
immunity
ART.
are
at
high
development
Mycobacterium
(Mtb)
infection.
Here
authors
compare
BAL
upon
vivo
Mtb
infection
find
(AM)
reduced
expression
M1-AM
AIDS Patient Care and STDs,
Journal Year:
2023,
Volume and Issue:
37(6), P. 284 - 296
Published: May 15, 2023
Acquired
immunodeficiency
syndrome
(AIDS),
caused
by
the
human
virus
(HIV),
has
become
a
heavy
burden
of
disease
and
an
important
public
health
problem
in
world.
Although
current
antiretroviral
therapy
(ART)
is
effective
at
suppressing
blood,
HIV
still
remains
two
different
types
reservoirs-the
latently
infected
cells
(represented
CD4+
T
cells)
tissues
containing
those
cells,
which
may
block
access
to
ART,
HIV-neutralizing
antibodies
latency-reversing
agents.
The
latter
focus
our
review,
as
blood
viral
load
drops
below
detectable
levels
after
deeper
more
systematic
understanding
tissue
reservoirs
imperative.
In
this
we
take
lymphoid
system
(including
lymph
nodes,
gut-associated
tissue,
spleen
bone
marrow),
nervous
system,
respiratory
reproductive
(divided
into
male
female),
urinary
order,
focusing
on
particularity
importance
each
infection,
infection
target
cell
specific
situation
quantified
DNA
or
RNA
evidence
compartmentalization
pharmacokinetics.
summary,
found
that
present
state
both
similarities
differences.
future,
therapeutic
principle
need
follow
respect
discrepancy
basis
grasping
commonality.
measures
taken
completely
eliminate
whole
body
cannot
be
generalized.
It
necessary
formulate
personalized
treatment
strategies
according
characteristics
various
tissues,
so
realize
prospect
curing
AIDS
soon
possible.
Drug and Alcohol Dependence,
Journal Year:
2024,
Volume and Issue:
255, P. 111066 - 111066
Published: Jan. 9, 2024
Identifying
co-occurring
mental
disorders
and
elevated
risk
is
vital
for
optimization
of
healthcare
processes.
In
this
study,
we
will
use
DeepBiomarker2,
an
updated
version
our
deep
learning
model
to
predict
the
adverse
events
among
patients
with
comorbid
post-traumatic
stress
disorder
(PTSD)
alcohol
(AUD),
a
high-risk
population.
Current Opinion in Virology,
Journal Year:
2024,
Volume and Issue:
66, P. 101410 - 101410
Published: May 7, 2024
Viral
infections,
including
those
affecting
the
respiratory
tract,
can
alter
composition
of
intestinal
microbiota,
which,
in
turn,
significantly
influence
both
innate
and
adaptive
immune
responses,
resulting
either
enhanced
pathogen
clearance
or
exacerbation
infection,
possibly
leading
to
inflammatory
complications.
A
deeper
understanding
interplay
between
microbiota
host
responses
context
viral
infections
(i.e.
gut-lung
axis)
is
necessary
develop
new
treatments.
This
review
highlights
key
mechanisms
by
which
its
metabolites,
act
locally
at
distant
organs
combat
viruses.
Therapeutics
aimed
harnessing
prevent
and/or
help
treat
represent
a
promising
avenue
for
future
investigation.
Oxford Open Immunology,
Journal Year:
2022,
Volume and Issue:
3(1)
Published: Jan. 1, 2022
Abstract
Current
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
vaccines,
based
on
the
ancestral
Wuhan
strain,
were
developed
rapidly
to
meet
needs
of
a
devastating
global
pandemic.
People
living
with
Human
Immunodeficiency
Virus
(PLWH)
have
been
designated
as
priority
group
for
SARS-CoV-2
vaccination
in
most
regions
and
varying
primary
courses
(two-
or
three-dose
schedule)
additional
boosters
are
recommended
depending
current
CD4+
T
cell
count
and/or
detectable
HIV
viraemia.
From
published
data,
licensed
vaccines
safe
PLWH,
stimulate
robust
responses
those
well
controlled
antiretroviral
therapy
high
counts.
Data
vaccine
efficacy
immunogenicity
remain,
however,
scarce
especially
people
advanced
disease.
A
greater
concern
is
potentially
diminished
immune
response
course
subsequent
boosters,
an
attenuated
magnitude
durability
protective
responses.
detailed
understanding
breadth
humoral
vaccination,
boosting
effects
natural
immunity
SARS-CoV-2,
more
diverse
populations
PLWH
spectrum
HIV-related
immunosuppression
therefore
critical.
This
article
summarizes
focused
studies
cellular
infection
provides
comprehensive
review
emerging
literature
Emphasis
placed
potential
effect
factors
presence
co-morbidities
modulating
remaining
challenges
informing
optimal
strategy
elicit
enduring
against
existing
variants
PLWH.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(2), P. 575 - 575
Published: Feb. 19, 2023
People
living
with
HIV
(PLWH)
may
be
at
risk
for
poor
immunogenicity
to
certain
vaccines,
including
the
ability
develop
immunological
memory.
Here,
we
assessed
T-cell
following
three
SARS-CoV-2
vaccine
doses
in
PLWH
versus
uninfected
controls.
Blood
was
collected
from
38
on
antiretroviral
therapy
and
24
age-matched
HIV-negative
controls,
pre-vaccination
after
1st/2nd/3rd
dose
of
without
prior
infection.
Flow
cytometry
used
assess
ex
vivo
immunophenotypes
intracellular
Tumor
necrosis
factor
(TNF)-α/interferon(IFN)-γ/interleukin(IL)-2
SARS-CoV-2-Spike-peptide
stimulation.
Comparisons
were
made
using
Wilcoxon
signed-rank
test
paired
variables
Mann-Whitney
unpaired.
In
PLWH,
Spike-specific
CD4
frequencies
plateaued
post-2nd
dose,
no
significant
differences
polyfunctional
SARS-CoV-2-specific
proportions
between
controls
post-3rd
dose.
had
higher
TNFα+CD4
T-cells
lower
IFNγ+CD8
than
seronegative
participants
Regardless
status,
an
increase
naive,
regulatory,
PD1+
observed
summary,
two
induced
a
robust
immune
response
which
maintained
3rd